Cargando…
A paradigm shift in the management of injectable drug use related upper extremity infections: Lessons learned during the COVID-19 pandemic
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Ltd on behalf of British Association of Plastic, Reconstructive and Aesthetic Surgeons.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9908616/ https://www.ncbi.nlm.nih.gov/pubmed/36812876 http://dx.doi.org/10.1016/j.bjps.2023.01.043 |
| _version_ | 1784884402525831168 |
|---|---|
| author | Jacob, DeAsia D. Gatherwright, James R. Djohan, Risal |
| author_facet | Jacob, DeAsia D. Gatherwright, James R. Djohan, Risal |
| author_sort | Jacob, DeAsia D. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9908616 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Published by Elsevier Ltd on behalf of British Association of Plastic, Reconstructive and Aesthetic Surgeons. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-99086162023-02-09 A paradigm shift in the management of injectable drug use related upper extremity infections: Lessons learned during the COVID-19 pandemic Jacob, DeAsia D. Gatherwright, James R. Djohan, Risal J Plast Reconstr Aesthet Surg Correspondence and Communications Published by Elsevier Ltd on behalf of British Association of Plastic, Reconstructive and Aesthetic Surgeons. 2023-03 2023-02-09 /pmc/articles/PMC9908616/ /pubmed/36812876 http://dx.doi.org/10.1016/j.bjps.2023.01.043 Text en © 2023 Published by Elsevier Ltd on behalf of British Association of Plastic, Reconstructive and Aesthetic Surgeons. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence and Communications Jacob, DeAsia D. Gatherwright, James R. Djohan, Risal A paradigm shift in the management of injectable drug use related upper extremity infections: Lessons learned during the COVID-19 pandemic |
| title | A paradigm shift in the management of injectable drug use related upper extremity infections: Lessons learned during the COVID-19 pandemic |
| title_full | A paradigm shift in the management of injectable drug use related upper extremity infections: Lessons learned during the COVID-19 pandemic |
| title_fullStr | A paradigm shift in the management of injectable drug use related upper extremity infections: Lessons learned during the COVID-19 pandemic |
| title_full_unstemmed | A paradigm shift in the management of injectable drug use related upper extremity infections: Lessons learned during the COVID-19 pandemic |
| title_short | A paradigm shift in the management of injectable drug use related upper extremity infections: Lessons learned during the COVID-19 pandemic |
| title_sort | paradigm shift in the management of injectable drug use related upper extremity infections: lessons learned during the covid-19 pandemic |
| topic | Correspondence and Communications |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9908616/ https://www.ncbi.nlm.nih.gov/pubmed/36812876 http://dx.doi.org/10.1016/j.bjps.2023.01.043 |
| work_keys_str_mv | AT jacobdeasiad aparadigmshiftinthemanagementofinjectabledruguserelatedupperextremityinfectionslessonslearnedduringthecovid19pandemic AT gatherwrightjamesr aparadigmshiftinthemanagementofinjectabledruguserelatedupperextremityinfectionslessonslearnedduringthecovid19pandemic AT djohanrisal aparadigmshiftinthemanagementofinjectabledruguserelatedupperextremityinfectionslessonslearnedduringthecovid19pandemic AT jacobdeasiad paradigmshiftinthemanagementofinjectabledruguserelatedupperextremityinfectionslessonslearnedduringthecovid19pandemic AT gatherwrightjamesr paradigmshiftinthemanagementofinjectabledruguserelatedupperextremityinfectionslessonslearnedduringthecovid19pandemic AT djohanrisal paradigmshiftinthemanagementofinjectabledruguserelatedupperextremityinfectionslessonslearnedduringthecovid19pandemic |